Hansa Biopharma AB (publ) HNSBF Price Prediction

The determination to procure Hansa Biopharma AB (publ) is entirely contingent on your individualistic risk tolerance. As you may discern, Hansa Biopharma AB (publ)'s value has experienced a fall of 0% during the preceding 24 hours, and Hansa Biopharma AB (publ) has incurred a decline of  over the prior 30-day duration. Consequently, the determination of whether or not to invest in Hansa Biopharma AB (publ) will hinge on whether such an investment aligns with your trading aspirations.

It appears that the mean value of Hansa Biopharma AB (publ) may potentially surge to $3.42 by the end of this year. Looking at Hansa Biopharma AB (publ)'s prospects in a more extended five-year timeline, the stock could potentially growth to as much as $3.25. However, given the market's unpredictability, it is vital to conduct thorough research before investing any funds into a particular company or asset.

Based on the our new experimental Hansa Biopharma AB (publ) forecast, the price of Hansa Biopharma AB (publ) will fall by -1.28% over the next week and reach $2.86 by June 13, 2026.

Based on the our new experimental Hansa Biopharma AB (publ) forecast, the price of Hansa Biopharma AB (publ) will increase by 2.22% over the next month and reach $2.96 by July 6, 2026.

As per our most recent prediction on Hansa Biopharma AB (publ)'s value in 2026, HNSBF is anticipated to fluctuate within the range of $2.83 and $3.42. However, it is crucial to bear in mind that the stock market is exceptionally unstable, and this projected Hansa Biopharma AB (publ) price forecast fails to consider sudden and extreme price fluctuations.

Hansa Biopharma AB (publ)'s future appears to be on an upward trend, with an maximum price of $3.25 projected after a period of five years. Based on the Hansa Biopharma AB (publ) forecast for 2031, Hansa Biopharma AB (publ)'s value may potentially reach its highest peak of approximately $3.25, while its lowest peak is anticipated to be around $2.90.

Based on the our new experimental Hansa Biopharma AB (publ) price prediction simulation, HNSBF’s value in 2026 expected to grow by 18.2% to $3.42 if the best happened. The price will be between $3.42 and $2.83 during 2026.

According to our latest experimental simulation for Hansa Biopharma AB (publ) price prediction, HNSBF’s value could rise by 24.56% to $3.61 in 2027, assuming the most favorable conditions. The price is projected to fluctuate between $3.61 and $2.76 throughout the year.

Our new experimental Hansa Biopharma AB (publ) price prediction model suggests that HNSBF’s value in 2028 could increase by 1.83% , reaching $2.95 in the best-case scenario. The price is expected to range between $2.95 and $2.14 during the year.

Based on our experimental forecast model, Hansa Biopharma AB (publ)'s value may experience a -9.59% fall in 2029, potentially reaching $2.62 under optimal conditions. The predicted price range for 2029 lies between $2.62 and $2.17.

Using our new experimental simulation for Hansa Biopharma AB (publ) price predictions, HNSBF’s value in 2030 is expected to rise by 8.34% , reaching $3.14 in the best scenario. The price is forecasted to range between $3.14 and $2.30 over the course of 2030.

Our experimental simulation indicates that Hansa Biopharma AB (publ)’s price could grow by 12.28% in 2031, potentially hitting $3.25 under ideal conditions. The price will likely fluctuate between $3.25 and $2.90 during the year.

Based on the findings from our latest experimental Hansa Biopharma AB (publ) price prediction, HNSBF could see a 36.3% rise in value, reaching $3.95 if the most positive scenario plays out in 2032. The price is expected to stay within a range of $3.95 and $3.16 throughout the year.

According to our experimental Hansa Biopharma AB (publ) price prediction, HNSBF’s value is anticipated to rise by 77.11% in 2033, with the highest potential price being $5.13. Throughout the year, HNSBF’s price could range from $5.13 and $3.96.

The results from our new Hansa Biopharma AB (publ) price prediction simulation suggest that HNSBF may rise by 106.42% in 2034, potentially reaching $5.98 under the best circumstances. The predicted price range for the year is between $5.98 and $4.96.

Based on our experimental forecast for Hansa Biopharma AB (publ)’s price, HNSBF could grow by 162.09% , with the value potentially hitting $7.60 in 2035. The expected price range for the year lies between $7.60 and $5.61.

Our recent Hansa Biopharma AB (publ) price prediction simulation suggests that HNSBF’s value might rise by 268.47% in 2036, possibly reaching $10.68 if conditions are optimal. The expected price range for 2036 is between $10.68 and $7.20.

According to the experimental simulation, Hansa Biopharma AB (publ)’s value could rise by 379.38% in 2037, with a high of $13.90 under favorable conditions. The price is expected to fall between $13.90 and $10.47 over the course of the year.